Clinical trial
Application of MRI Radiomics to Improve Diagnosis and Pharmacologica Prognosis of Autism Spectrum Disorder
NCT05439954 is registered in ClinicalTrials.gov with Qingling Chen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Application of MRI Radiomics to Improve Diagnosis and Pharmacologica Prognosis of Autism Spectrum Disorder
- Lead sponsor
- Qingling Chen
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 1, 2020
- Completion date
- December 1, 2024
- Enrollment
- 230 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.